Reduced Nrf2 and Phase II enzymes expression in immune-mediated spinal cord motor neuron injury

Neurological Research

Volumn 32, Issue 5, 2010, Pages 460-465

  Guo, Yansu ^b   Liu, Yaling ^b   Xu, Lei ^b   Wu, Dongxia ^b   Wu, Hongran ^b   Li, Chun Yan ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b NONE

Author keywords

Immune mediated motor neuron injury; Nrf2 ARE; Phase II enzymes

Indexed keywords

GLUTATHIONE TRANSFERASE; HEME OXYGENASE 1; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; TRANSCRIPTION FACTOR NRF2; ANTIOXIDANT; BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GUINEA PIG; IMMUNE RESPONSE; IMMUNOREACTIVITY; MALE; MOTONEURON; NONHUMAN; PROTEIN EXPRESSION; SPINAL CORD DORSAL HORN; SPINAL CORD INJURY; ACUTE DISEASE; ANIMAL; CHRONIC DISEASE; DISEASE MODEL; DRUG DETOXIFICATION; GLIA; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; METABOLISM; PARALYSIS; PATHOLOGY; PHYSIOLOGY; POSTERIOR HORN CELL; SPINAL CORD;

ACUTE DISEASE; ANIMALS; ANTIOXIDANTS; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; GUINEA PIGS; IMMUNOHISTOCHEMISTRY; MALE; METABOLIC DETOXICATION, PHASE II; MOTOR NEURONS; NEUROGLIA; PARALYSIS; POSTERIOR HORN CELLS; SPINAL CORD; SPINAL CORD INJURIES;

EID: 77952810669     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/174313209X385563     Document Type: Article

References (18)

1. Smith RG, Siklos L, Alexianu ME, et al. Autoimmunity and ALS. Neurology 1996; 47: 40S-46S
2. Engelhardt JI, Appel SH, Killian JM. Experimental autoimmune motor neuron disease. Ann Neurol 1989; 26: 368-376
3. Engelhardt JI, Appel SH, Killian JM. Motor neuron destruction in guinea pigs immunized with bovine spinal cord ventral horn homogenate: Experimental autoimmune gray matter disease. J Neuroimmunol 1990; 27: 21-31
4. Simpson EP, Yen AA, Appel SH. Oxidative stress: A common denominator in the pathogenesis of amyotrophic lateral sclerosis. Curr Opin Rheumatol 2003; 15: 730-736
5. Chan JY, Han XL, Kan YW. Cloning of Nrf1, an NF-E2-related transcription factor, by genetic selection in yeast. Proc Natl Acad Sci U S A 1993; 90: 11371-11375
6. Moi P, Chan K, Asunis I, et al. Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region, Proc Natl Acad Sci U S A 1994; 91: 9926-9930
7. Kobayashi A, Ito E, Toki T, et al. Molecular cloning and functional characterization of a new Cap'n'Collar family transcription factor Nrf3. J Biol Chem 1999; 274: 6443-6452
8. Oyake T, Itoh K, Motohashi H, et al. Bach proteins belong to a novel family of BTB-basic leucine zipper transcription factors that interact with MafK and regulate transcription through the NF-E2 site. Mol Cell Biol 1996; 16: 6083-6095
9. Venugopal R, Jaiswal AK. Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response elementmediated expression of NAD(P)H:quinone oxidoreductase1 gene. Proc Natl Acad Sci U S A 1996; 93: 14960-14965
10. Venugopal R, Jaiswal AK. Nrf2 and Nrf1 in association with Jun proteins regulate antioxidant response element-mediated expression and coordinated induction of genes encoding detoxifying enzymes. Oncogene 1998; 17: 3145-3156
11. Itoh K, Chiba T, Takahashi S, et al. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun 1997; 236: 313-322
12. Alam J, Stewart D, Touchard C, et al. Nrf2, a Cap'n'Collar transcription factor, regulates induction of the heme oxygenase-1 gene. J Biol Chem 1999; 274: 26071-26078
13. Iida K, Itoh K, Kumagai Y, et al.Oyasu R, Hattori K, Kawai K, Shimazui T, Akaza H, Yamamoto M. (2004) Nrf2 is essential for the chemopreventive efficacy of oltipraz against urinary bladder carcinogenesis. Cancer Res 2004;, Cancer. Res, 64: 6424-6431
14. Guo Y, Liu Y, Xu L, et al. Astrocytic pathology in the immunemediated motor neuron injury. Amyotroph Lateral Scler 2007; 8: 230-234
15. Lee JM, Li J, Johnson DA, et al.Stein TD, Kraft AD, Calkins MJ, Jakel RJ, Johnson JA. (2005) Nrf2, a multi-organ protector? FASEB J 2005; 19: 1061-1066
16. Giudice A, Montella M. Activation of the Nrf2-ARE signaling pathway: a promising strategy in cancer prevention. Bioessays 2006; 28: 169-181
17. Lee JS, Surh YJ. Nrf2 as a novel molecular target for chemoprevention. Cancer Lett 2005;, Cancer. Lett, 224: 171-184
18. Yu R, Mandlekar S, Lei W, et al. p38 mitogen-activated protein kinase negatively regulates the induction of phase II drugmetabolizing enzymes that detoxify carcinogens. J Biol Chem 2000; 275: 2322-2327